Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

November 11, 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

October 29, 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

May 06, 2024

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

News Conference News VIVA 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

November 01, 2023

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

September 17, 2022

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

News Conference News TCT 2021

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

November 03, 2021

FlowTriever Looks Good for Acute PE in Interim FLASH Results

News Conference News TCT 2020

FlowTriever Looks Good for Acute PE in Interim FLASH Results

October 18, 2020

Venous Stents: Long-term Follow-up Plus a New Contender

News Conference News ISET 2020

Venous Stents: Long-term Follow-up Plus a New Contender

January 24, 2020

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

News Conference News ISET 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

February 08, 2019

News Conference News ISET 2018

‘Bioconvertible’ IVC Filter Does Its Job Then Moves On: SENTRY Trial

February 15, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.